Comprehensive Psychiatry
Volume 50, Issue 5 , Pages 437-442 , September 2009

Obsessive-compulsive symptoms and disorder in patients with schizophrenia treated with clozapine or haloperidol

  • Antonio R. Sa

      Affiliations

    • Department and Institute of Psychiatry, Clinical Hospital, Faculty of Medicine, University of São Paulo, Brazil
    • Corresponding Author InformationCorresponding author.
    • ,
  • Ana G. Hounie

      Affiliations

    • Department and Institute of Psychiatry, Clinical Hospital, Faculty of Medicine, University of São Paulo, Brazil
    • ,
  • Aline S. Sampaio

      Affiliations

    • Department and Institute of Psychiatry, Clinical Hospital, Faculty of Medicine, University of São Paulo, Brazil
    • ,
  • Jony Arrais

      Affiliations

    • Institute of Mathematics and Statistics, University of São Paulo, Brazil
    • ,
  • Euripedes C. Miguel

      Affiliations

    • Department and Institute of Psychiatry, Clinical Hospital, Faculty of Medicine, University of São Paulo, Brazil
    • ,
  • Helio Elkis

      Affiliations

    • Department and Institute of Psychiatry, Clinical Hospital, Faculty of Medicine, University of São Paulo, Brazil

References 

  1. Berrios GE. Obsessive-compulsive disorder: its conceptual history in France during the 19th century. Compr Psychiatry. 1989;30(4):283–295
  2. Poyurovsky M, Weizman A, Weizman R. Obsessive-compulsive disorder in schizophrenia: clinical characteristics and treatment. CNS Drugs. 2004;18:989–1010
  3. Kayahan B, Ozturk O, Veznedaroglu B, Eraslan D. Obsessive-compulsive symptoms in schizophrenia: prevalence and clinical correlates. Psychiatry Clin Neurosci. 2005;59(3):291–295
  4. De Haan L, Oekeneva A, Van Amelsvoort T, Linszen D. Obsessive-compulsive disorder and treatment with clozapine in 200 patients with recent-onset schizophrenia or related disorders. Eur Psychiatry. 2004;19(8):524
  5. Fenton WS, McGlashan TH. The prognostic significance of obsessive-compulsive symptoms in schizophrenia. Am J Psychiatry. 1986;143:437–441
  6. Berman I, Kalinowski A, Berman SM, et al. Obsessive and compulsive symptoms in chronic schizophrenia. Compr Psychiatry. 1995;36(1):6–10
  7. Lysaker PH, Marks KA, Picone JB, et al. Obsessive and compulsive symptoms in schizophrenia: clinical and neurocognitive correlates. J Nerv Ment Dis. 2000;188(2):78–83
  8. Lieberman JA, Stroup TS, McEvoy JP, et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med. 2005;353(12):1209–1223[electronic publication 2005 Sep 19]
  9. Poyurovsky M, Hramenkov S, Isakov V, et al. Obsessive-compulsive disorder in hospitalized patients with chronic schizophrenia. Psychiatry Res. 2001;102(1):49–57
  10. Poyurovsky M, Dorfman-Etrog P, Hermesh H, Munitz H, Tollefson GD, Weizman A. Beneficial effect of olanzapine in schizophrenic patients with obsessive-compulsive symptoms. Int Clin Psychopharmacol. 2000;15(3):169–173
  11. Whitney KA, Fastenau PS, Evans JD, Lysaker PH. Comparative neuropsychological function in obsessive-compulsive disorder and schizophrenia with and without obsessive-compulsive symptoms. Schizophr Res. 2004;69(1):75–83
  12. Zohar J. Is there room for a new diagnostic subtype: the schizo-obsessive subtype. CNS Spectr. 1997;2:49–50
  13. Baker RW, Chengappa KN, Baird JW, et al. Emergence of obsessive compulsive symptoms during treatment with clozapine. J Clin Psychiatry. 1992;53:439–442
  14. de Haan L, Linszen DH, Gorsira R. Clozapine and obsessions in patients with recent-onset schizophrenia and other psychotic disorders. J Clin Psychiatry. 1999;60(6):364–365
  15. Lykouras L, Alevizos B, Michalopoulou P, et al. Obsessive-compulsive symptoms induced by atypical antipsychotics. A review of the reported cases. Prog Neuropsychopharmacol Biol Psychiatry. 2003;27:333–346
  16. Eales MJ, Layeni AO. Exacerbation of obsessive-compulsive symptoms associated with clozapine. Br J Psychiatry. 1994;164(5):687–688
  17. LaPorta LD. More on obsessive-compulsive symptoms and clozapine. J Clin Psychiatry. 1994;55(7):312
  18. Lin SK, Su SF, Pan CH. Higher plasma drug concentration in clozapine-treated schizophrenic patients with side effects of obsessive/compulsive symptoms. Ther Drug Monit. 2006;28(3):303–307
  19. Tranulis C, Potvin S, Gourgue M, et al. The paradox of quetiapine in obsessive-compulsive disorder. CNS Spectr. 2005;10(5):356–361
  20. de Haan L, Beuk N, Hoogenboom B, et al. Obsessive-compulsive symptoms during treatment with olanzapine and risperidone: a prospective study of 113 patients with recent-onset schizophrenia or related disorders. J Clin Psychiatry. 2002;63(2):104–107
  21. Dryden-Edwards RC, Reiss AL. Differential response of psychotic and obsessive symptoms to risperidone in an adolescent. J Child Adolesc Psychopharmacol. 1996;6(2):139–145
  22. Howland RH. Chlorpromazine and obsessive-compulsive symptoms. Am J Psychiatry. 1996;153:1503
  23. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders. 4th ed.. Washington, DC: American Psychiatric Association; 1994;
  24. First MB, Spitzer RL, Gibbon M, Willians JBW. Structured Clinical Interview for DSM-IV Axis I Disorders-Patient Edition (Version 2.0). Biometric Research Department. New York, NY: New York State Psychiatric Institute; 1995;
  25. Goodman WK, Price LH, Rasmussen AS, et al. The Yale-Brown Obsessive Compulsive Scale: I. Development, use and reliability. Arch Gen Psychiatry. 1989;46:1006–1011
  26. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13:261–276
  27. Guy W. ECDEU Assessment manual for psychopharmacology: Publication 76-338.. Washington: US Department of Health, Education and Welfare; 1976;
  28. Westphal C. Über Zwangsvorstellungen. Arch Psychiatr Nevenkr. 1878;8:734–750
  29. Bleuler E. In:  Zinken J editors. Dementia praecox, or the group of schizophrenias (1911). New York: International Universities Press; 1950;
  30. Insel TR, Akiskal HS. Obsessive-compulsive disorder with psychotic features: a phenomenologic analysis. Am J Psychiatry. 1986;143(12):1527–1533
  31. Poyurovsky M, Koran LM. Obsessive-compulsive disorder (OCD) with schizotypy vs. schizophrenia with OCD: diagnostic dilemmas and therapeutic implications. J Psychiatr Res. 2005;39(4):399–408
  32. Conley RR, Kelly DL. Management of treatment resistance in schizophrenia. Biol Psychiatry. 2001;50(11):898–911[Review]
  33. Elkis H. Treatment-resistant schizophrenia. Psychiatr Clin North Am. 2007;30(3):511–533
  34. Shavitt RG, Belotto C, Curi M, et al. Clinical features associated with treatment response in obsessive-compulsive disorder. Compr Psychiatry. 2006;47(4):276–281[electronic publication 2006 Apr 19]
  35. Grimes DA, Schulz KF. An overview of clinical research: the lay of the land. Lancet. 2002;359(9300):57–61[Review]
  36. Denys D, de Geus F, van Megen HJ, Westenberg HG. A double-blind, randomized, placebo-controlled trial of quetiapine addition in patients with obsessive-compulsive disorder refractory to serotonin reuptake inhibitors. J Clin Psychiatry. 2004;65(8):1040–1048

PII: S0010-440X(08)00171-5

doi: 10.1016/j.comppsych.2008.11.005

Comprehensive Psychiatry
Volume 50, Issue 5 , Pages 437-442 , September 2009

Article Tools